The causes of multiple sclerosis and amyotrophic lateral sclerosis have long remained
elusive. A new category of pathogenic components, normally dormant within human genomes, …

Objective Differentiation of oligodendroglial precursor cells is crucial for central nervous
system remyelination and is influenced by both extrinsic and intrinsic factors. Recent studies …

Objective To identify micro RNA s (mi RNA s) regulated by anti‐α4 integrin monoclonal
antibody therapy (natalizumab) in the peripheral blood of patients with relapsing‐remitting (RR) …

The alternative SDF-1 (stromal cell derived factor-1) receptor, CXCR7, has been suggested
to act as either a scavenger of extracellular SDF-1 or a modulator of the primary SDF-1 …

Fingolimod (also known as FTY720) is an orally available sphingosine-1-phosphate (S1P)
receptor modulator that has unique and potent immunoregulatory properties. Mechanistic …

Axonal degeneration is central to clinical disability and disease progression in multiple
sclerosis (MS). Myeloid cells such as brain-resident microglia and blood-borne monocytes are …

Neuroinflammation is a pathophysiological hallmark of multiple sclerosis and has a close
mechanistic link to neurodegeneration. Although this link is potentially targetable, robust …

Myelination is a central nervous system (CNS) process wherein oligodendrocyte‐axon
interactions lead to the establishment of myelin sheaths that stabilize, protect, and electrically …

One of the most striking features of the injured mature peripheral nervous system is the
ability to regenerate. The lesioned peripheral nervous system displays stereotypic …

The evolutionary acquisition of myelin sheaths around large caliber axons in the central
nervous system (CNS) represented a milestone in the development of vertebrate higher brain …